MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mds.28144

Медицинская библиотека · Movement disorders : official journal of the Movement Disorder Society · 2020

Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset.

Schierding William, Farrow Sophie, Fadason Tayaza, Graham Oscar E E, Pitcher Toni L, Qubisi Sara, Davidson Alan J, Perry Jo K, Anderson Tim J, Kennedy Martin A, Cooper Antony, O'Sullivan Justin M

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

GBA mutations are numerically the most significant genetic risk factor for Parkinson's disease (PD), yet these mutations have low penetrance, suggesting additional mechanisms.

OBJECTIVES

The objective of this study was to determine if the penetrance of GBA in PD can be explained by regulatory effects on GBA and modifier genes.

METHODS

Genetic variants associated with the regulation of GBA were identified by screening 128 common single nucleotide polymorphisms (SNPs) in the GBA locus for spatial cis-expression quantitative trail locus (supported by chromatin interactions).

RESULTS

We identified common noncoding SNPs within GBA that (1) regulate GBA expression in peripheral tissues, some of which display α-synuclein pathology and (2) coregulate potential modifier genes in the central nervous system and/or peripheral tissues. Haplotypes based on 3 of these SNPs delay disease onset by 5 years. In addition, SNPs on 6 separate chromosomes coregulate GBA expression specifically in either the substantia nigra or cortex, and their combined effect potentially modulates motor and cognitive symptoms, respectively.

CONCLUSIONS

This work provides a new perspective on the haplotype-specific effects of GBA and the genetic etiology of PD, expanding the role of GBA from the gene encoding the β-glucocerebrosidase (GCase) to that of a central regulator and modifier of PD onset, with GBA expression itself subject to distant regulation. Some idiopathic patients might possess insufficient GBA-encoded GCase activity in the substantia nigra as the result of distant regulatory variants and therefore might benefit from GBA-targeting therapeutics. The SNPs' regulatory impacts provide a plausible explanation for the variable phenotypes also observed in GBA-centric Gaucher's disease and dementia with Lewy bodies. © 2020 The Authors. Movement Disorders published by Wiley Periodicals, LLC on behalf of International Parkinson and Movement Disorder Society.

Для цитирования: Schierding William, Farrow Sophie, Fadason Tayaza, Graham Oscar E E, Pitcher Toni L, Qubisi Sara, Davidson Alan J, Perry Jo K, Anderson Tim J, Kennedy Martin A, Cooper Antony, O'Sullivan Justin M. Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset.. Movement disorders : official journal of the Movement Disorder Society. 2020. DOI: 10.1002/mds.28144.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.